This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Mvrix Co., Ltd., Sungkyunkwan University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: The Innovations of Wonbeom Park
Introduction
Wonbeom Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the targeting ability of therapeutic agents through advanced nanoparticle technology.
Latest Patents
Wonbeom Park holds a patent for an "Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein." This invention relates to a lipid nanoparticle that includes an antibody conjugated with a membrane scaffold protein. The nanoparticle is designed to be easily produced and exhibits excellent specific targeting ability, making it a valuable asset in therapeutic applications. He has 1 patent to his name.
Career Highlights
Throughout his career, Wonbeom Park has worked with esteemed institutions, including Sungkyunkwan University and Mvrix Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Dae-Hyuk Kweon and Suhyun Kim. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.
Conclusion
Wonbeom Park's contributions to the field of biotechnology through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in targeted drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile